EN DE

Health In Tech, Inc (HIT) Fair Value & Analysis

Technology · US · Market cap $70.8M

HI Health In Tech, Inc logo Health In Tech, Inc HIT · US
Price$1.12
Fair Value$0.3100
Upside-72.3%
Quality50/100
Watch Health In Tech, Inc for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Loss-making · -2.4% net margin
negative free cash flow
Trails peers (1/10)
Narrow moat 13/100
Evidence: Medium Range $0.2300 – $0.3900 Share as image

Fair value as of: Jul 26, 2026

From 6 valuation models · updated 16 days ago

Share price +5.7% over the past month.

A solid business, but screening 72% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case ($0.3900). The favourable scenario is already priced in.
  • Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (19 months)

$7.46 $0.5551 Fair Value $0.3100 Dec 2024 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 26, 2026.

How to read this chart

19‑month range $0.5551 – $7.46 · fair‑value band $0.2300 – $0.3900 · the $1.12 price screens above the $0.3100 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 26, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Health In Tech, Inc (HIT) currently trades at $1.12, while our model-based Fair Value estimate is $0.3100, implying the stock looks roughly 72.3% overvalued today. The Quality Score stands at 50/100 (solid quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Health In Tech, Inc generated revenue of $34.1M at a net margin of -2.4%. Revenue grew 9.4% year over year. It earns a return on equity of -4.5%. The balance sheet holds a net cash position of $7.5M. Fundamentals as of Jul 26, 2026

Our scenario range runs from $0.2300 (bear case) to $0.3900 (bull case); at $1.12, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 72% below its 52-week high and 84% above its 52-week low, currently below its 200-day average. For context, the median of 10 Technology peers we cover trades at -27% fair-value upside, at -72%, HIT screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
P/E Multiple $0.2300 $0.3100 $0.3900 63
Residual Income $0.2300 $0.2400 $0.2300 61
P/B Multiple $0.3000 $0.4000 $0.5000 55
All 6 models by family
Earnings-Based
Graham-Dodd $0.1600 $1.13 $1.58 54
Lynch FV $0.5800 $0.8300 $1.08 50
Multiples
P/E Multiple $0.2300 $0.3100 $0.3900 63
P/B Multiple $0.3000 $0.4000 $0.5000 55
Asset-Based
NCAV (Graham) $0.1600 $0.2100 $0.3200 50
Economic Profit
Residual Income $0.2300 $0.2400 $0.2300 61

Widest divergence: Earnings-Based ($0.8300) versus Asset-Based ($0.2100). Highest evidence: P/E Multiple (63).

Notify me when HIT reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $34.1M
Revenue growth (YoY) +9.4%
Net margin -2.4%
Return on equity -4.5%
Free cash flow −$56.1K FY2025
Operating margin -24.6%
More key figures
EPS (TTM) $-0.0200
EPS growth (YoY) +10.3%
Net cash $7.5M FY2025

Figures from reported company fundamentals · as of Jul 26, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 50/100

Of which business quality 55 · Market factors (momentum, volatility) 12

Profitability 61
Margins and returns on capital today
Quality Growth 58
Are margins and returns improving?
Cashflow 39
Earnings quality: real cash, not paper profit
Fin. Strength 80
Balance sheet, leverage, solvency risk
Investment 53
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 22
Price trend over the last 3–12 months (market factor)
52W Momentum 8
Distance to the 52-week high (market factor)
Net Issuance 32
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which …

Full company description

Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers. It also provides health intelligence (HI) cards to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2025 · reported fiscal years

Health In Tech, Inc reported revenue of $33.3M in FY2025 versus $5.8M in FY2022, a compound +79.4%/yr. Reported net income was $1.3M in FY2025, compounding +152.2%/yr from FY2022.

Growth Quality 58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
$33.3M
Latest YoY
+71.0%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+79.4%
Revenue +79.4%/yr
FY22 $5.8M
FY23 $19.2M
FY24 $19.5M
FY25 $33.3M
Net income +152.2%/yr
FY22 $79.7K
FY23 $2.5M
FY24 $670K
FY25 $1.3M

HIT screens 72% overvalued. Compare with SAP SE →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Health In Tech, Inc Fair Value". https://www.fairvalue-calculator.com/stock/HIT

Peer Group

Software - Application · 709 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 50 · Below median
Fair Value upside −72% · Bottom 25%
Return on assets -3% · Below median
Net margin (TTM) -2% · Below median
Operating margin (TTM) -25% · Bottom 25%
Revenue growth 9% · Above median

Valuation Multiples vs Software - Application median · lower = cheaper

P/B 4.14× · Pricier than median
P/S (TTM) 2.08× · Pricier than median
EV/EBITDA 26.0× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 47 · sector 38
PAST 0 · sector 13
HEALTH 0 · sector 98
DIVIDEND 0 · sector 28

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Software - Application stocks, each showing price versus our Fair Value estimate (as of Jul 26, 2026).

Stock Price Fair Value vs Fair Value
SAP SE SAPS C$12.69 C$16.26 +28%
Shopify Inc SHOP C$173.23 C$20.54 -88%
Uber Technologies, Inc UBER $72.67 $51.11 -30%
Salesforce, Inc CRM $170.77 $182.10 +7%
ServiceNow, Inc NOW $107.71 $33.12 -69%
Cadence Design Systems, Inc CDNS $384.17 $80.41 -79%
Snowflake Inc SNOW $271.87 $34.04 -87%
Adobe Inc ADBE $230.61 $379.48 +65%
Automatic Data Processing, Inc ADP $241.92 $177.51 -27%
Intuit Inc INTU $291.09 $258.69 -11%

Compare Health In Tech, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Health In Tech, Inc (HIT) overvalued or undervalued?
As of Jul 26, 2026, our model estimates a fair value of $0.3100 versus a price of $1.12, about −72% (overvalued).
What is the fair value of HIT?
Our model-based fair value for Health In Tech, Inc is $0.3100 (as of Jul 26, 2026), built from audited fundamentals. The current price is $1.12.
What is the quality score of HIT?
Health In Tech, Inc has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Health In Tech, Inc (HIT)?
Health In Tech, Inc reported trailing-twelve-month revenue of about $34.1M (latest available figure, as of Jul 26, 2026).
What is the net profit margin of HIT?
The net profit margin of Health In Tech, Inc is about -2.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Health In Tech, Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.